Literature DB >> 3930154

Response of BALB/c mice to leishmanial infection.

J M Blackwell, B Roberts, J Alexander.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 3930154     DOI： 10.1007/978-3-642-70740-7_15

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  6 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

Authors:  J O Hill
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

3.  The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.

Authors:  K C Carter; A J Baillie; A B Mullen
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

4.  Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response.

Authors:  Karen Bryson; Sébastien Besteiro; H Adrienne McGachy; Graham H Coombs; Jeremy C Mottram; James Alexander
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

5.  Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis.

Authors:  Helen Ashwin; Karin Seifert; Sarah Forrester; Najmeeyah Brown; Sandy MacDonald; Sally James; Dimitris Lagos; Jon Timmis; Jeremy C Mottram; Simon L Croft; Paul M Kaye
Journal:  Wellcome Open Res       Date:  2019-01-02

6.  T cell and non-T cell compartments can independently determine resistance to Leishmania major.

Authors:  A H Shankar; R G Titus
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.